Cargando…
Perfil epidemiológico de la artritis reumatoide
BACKGROUND: Rheumatoid arthritis affects approximately between 0.3 and 1.2% of the world population. In Latin America, different studies have estimated a prevalence between 0.2 and 0.5% in the population over 16 years of age. OBJECTIVE: To identify the epidemiological profile of rheumatoid arthritis...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Mexicano del Seguro Social
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599789/ https://www.ncbi.nlm.nih.gov/pubmed/37757464 http://dx.doi.org/10.5281/zenodo.8316427 |
_version_ | 1785125843066945536 |
---|---|
author | Miguel-Lavariega, Deyanira Elizararrás-Rivas, Jesús Villarreal-Ríos, Enrique Baltiérrez-Hoyos, Rafael Velasco-Tobón, Ulises Vargas-Daza, Emma Rosa Galicia-Rodríguez, Liliana |
author_facet | Miguel-Lavariega, Deyanira Elizararrás-Rivas, Jesús Villarreal-Ríos, Enrique Baltiérrez-Hoyos, Rafael Velasco-Tobón, Ulises Vargas-Daza, Emma Rosa Galicia-Rodríguez, Liliana |
author_sort | Miguel-Lavariega, Deyanira |
collection | PubMed |
description | BACKGROUND: Rheumatoid arthritis affects approximately between 0.3 and 1.2% of the world population. In Latin America, different studies have estimated a prevalence between 0.2 and 0.5% in the population over 16 years of age. OBJECTIVE: To identify the epidemiological profile of rheumatoid arthritis. MATERIAL AND METHODS: Descriptive cross-sectional design carried out in an urban population of a social security institution in Mexico. The information of the clinical file of 373 patients was studied. The epidemiological profile included the sociodemographic dimension, family history, health, clinical, therapeutic, biochemical, extra-articular manifestations and complications. Statistical analysis percentages, means, confidence intervals for percentages and confidence intervals for averages were calculated. RESULTS: The wrists were the most affected joints with 44.6% (95% CI: 39.5-49.6%). The extra-articular manifestation with the highest prevalence was asthenia with 9.9% (95% CI: 6.9-12.9%); predominant diagnosis according to ICD-10 was seropositive rheumatoid arthritis with 59.8% (95% CI: 54.8-64.8%), and the rheumatoid factor was highly positive in 78.3% (95% CI: 74.1-82.5%); predominant treatment was with combined therapy at diagnosis in 97.6% (95% CI: 96.0-99.1%). The duration of treatment was > 10 years in 34.1% (95% CI: 29.2-38.8%). CONCLUSIONS: This work has described the epidemiological profile of the patient with rheumatoid arthritis in different dimensions. |
format | Online Article Text |
id | pubmed-10599789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Instituto Mexicano del Seguro Social |
record_format | MEDLINE/PubMed |
spelling | pubmed-105997892023-10-26 Perfil epidemiológico de la artritis reumatoide Miguel-Lavariega, Deyanira Elizararrás-Rivas, Jesús Villarreal-Ríos, Enrique Baltiérrez-Hoyos, Rafael Velasco-Tobón, Ulises Vargas-Daza, Emma Rosa Galicia-Rodríguez, Liliana Rev Med Inst Mex Seguro Soc Aportación Original BACKGROUND: Rheumatoid arthritis affects approximately between 0.3 and 1.2% of the world population. In Latin America, different studies have estimated a prevalence between 0.2 and 0.5% in the population over 16 years of age. OBJECTIVE: To identify the epidemiological profile of rheumatoid arthritis. MATERIAL AND METHODS: Descriptive cross-sectional design carried out in an urban population of a social security institution in Mexico. The information of the clinical file of 373 patients was studied. The epidemiological profile included the sociodemographic dimension, family history, health, clinical, therapeutic, biochemical, extra-articular manifestations and complications. Statistical analysis percentages, means, confidence intervals for percentages and confidence intervals for averages were calculated. RESULTS: The wrists were the most affected joints with 44.6% (95% CI: 39.5-49.6%). The extra-articular manifestation with the highest prevalence was asthenia with 9.9% (95% CI: 6.9-12.9%); predominant diagnosis according to ICD-10 was seropositive rheumatoid arthritis with 59.8% (95% CI: 54.8-64.8%), and the rheumatoid factor was highly positive in 78.3% (95% CI: 74.1-82.5%); predominant treatment was with combined therapy at diagnosis in 97.6% (95% CI: 96.0-99.1%). The duration of treatment was > 10 years in 34.1% (95% CI: 29.2-38.8%). CONCLUSIONS: This work has described the epidemiological profile of the patient with rheumatoid arthritis in different dimensions. Instituto Mexicano del Seguro Social 2023 /pmc/articles/PMC10599789/ /pubmed/37757464 http://dx.doi.org/10.5281/zenodo.8316427 Text en Licencia CC 4.0 (BY-NC-ND) © 2023 Revista Médica del Instituto Mexicano del Seguro Social. https://creativecommons.org/licenses/by-nc-nd/4.0/Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional. |
spellingShingle | Aportación Original Miguel-Lavariega, Deyanira Elizararrás-Rivas, Jesús Villarreal-Ríos, Enrique Baltiérrez-Hoyos, Rafael Velasco-Tobón, Ulises Vargas-Daza, Emma Rosa Galicia-Rodríguez, Liliana Perfil epidemiológico de la artritis reumatoide |
title | Perfil epidemiológico de la artritis reumatoide |
title_full | Perfil epidemiológico de la artritis reumatoide |
title_fullStr | Perfil epidemiológico de la artritis reumatoide |
title_full_unstemmed | Perfil epidemiológico de la artritis reumatoide |
title_short | Perfil epidemiológico de la artritis reumatoide |
title_sort | perfil epidemiológico de la artritis reumatoide |
topic | Aportación Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599789/ https://www.ncbi.nlm.nih.gov/pubmed/37757464 http://dx.doi.org/10.5281/zenodo.8316427 |
work_keys_str_mv | AT miguellavariegadeyanira perfilepidemiologicodelaartritisreumatoide AT elizararrasrivasjesus perfilepidemiologicodelaartritisreumatoide AT villarrealriosenrique perfilepidemiologicodelaartritisreumatoide AT baltierrezhoyosrafael perfilepidemiologicodelaartritisreumatoide AT velascotobonulises perfilepidemiologicodelaartritisreumatoide AT vargasdazaemmarosa perfilepidemiologicodelaartritisreumatoide AT galiciarodriguezliliana perfilepidemiologicodelaartritisreumatoide |